Key result
This is a study protocol for a randomized controlled trial evaluating prophylactic endoluminal negative pressure therapy in 40 patients undergoing esophagectomy; no results are reported.
Why the study?
Does prophylactic endoluminal negative pressure therapy reduce postoperative length of hospitalization in high-risk patients undergoing minimally invasive transthoracic Ivor Lewis oesophagectomy?
RCT (n=40)
Randomized
Yes
Does prophylactic endoluminal negative pressure therapy reduce postoperative length of hospitalization in high-risk patients undergoing minimally invasive transthoracic Ivor Lewis oesophagectomy?
Answers are grounded in this paper and cite their sources.
This study protocol outlines a randomized controlled trial to evaluate whether prophylactic endoluminal negative pressure therapy reduces hospital length of stay in high-risk patients undergoing minimally invasive esophagectomy.
Introduction: Anastomotic leakage (AL) accounts for a significant proportion of morbidity following oesophagectomy. Endoluminal negative pressure (ENP) therapy via a specifically designed polyurethane foam (EsoSponge ® , B.Braun Medical, Melsungen, Germany) has become the standard of care for AL in many specialized centres. The prophylactic (pENP) application of this technique aims to reduce postoperative morbidity and is a novel approach which has not yet been investigated in a prospective study. The aim of this study is therefore to assess the effect of pENP at the anastomotic site in high-risk patients undergoing minimally invasive transthoracic Ivor Lewis oesophagectomy. Methods and analysis: The study design is a prospective, multi-centre, two-arm, parallel-group, randomised controlled trial and will be conducted in two phases. Phase one is a randomised feasibility and safety pilot trial involving 40 consecutive patients. After definitive sample size calculation, additional patients will be included accordingly during phase two. The primary outcome of the study will be the postoperative length of hospitalization until reaching previously defined “fit for discharge criteria”. Secondary outcomes will include postoperative morbidity, mortality and postoperative AL-rates based on 90-day follow-up. A confirmatory analysis based on intention-to-treat will be performed. Ethics and dissemination: The ethics committee of the University of Zurich approved this study (2019-00562), which has been registered with ClinicalTrials.gov on 14.11.2019 (NCT04162860) and the Swiss National Clinical Trials Portal (SNCTP000003524). The results of the study will be published and presented at appropriate conferences.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2021) conducted an RCT in High-risk patients undergoing minimally invasive transthoracic Ivor Lewis oesophagectomy (n=40). Prophylactic endoluminal negative pressure (pENP) therapy was evaluated on Postoperative length of hospitalization until reaching previously defined 'fit for discharge criteria'. This is a study protocol for a randomized controlled trial evaluating prophylactic endoluminal negative pressure therapy in 40 patients undergoing esophagectomy; no results are reported.
Synapse has enriched 10 related papers. Consider them for comparative context: